Document Detail

The safety of escitalopram during pregnancy and breastfeeding: a comprehensive review.
MedLine Citation:
PMID:  23044635     Owner:  NLM     Status:  Publisher    
OBJECTIVE: Escitalopram (ESC) is considered one of the most effective selective serotonin reuptake inhibitors for the treatment of major depression. However, little is known on its potential risk of inducing major malformations (MMs) and perinatal complications (PCs). Hence, aim of the present study is to provide a comprehensive review of the available literature on the safety profile of ESC during pregnancy and breastfeeding. METHODS: MEDLINE and PubMed databases were searched for English language articles by using the following keywords: escitalopram, selective serotonin reuptake inhibitors, major malformations, perinatal complications, pregnancy, and breastfeeding. RESULTS: Although some cases of MMs have been reported after maternal exposure to ESC during early pregnancy, the rate of these adverse events is substantially in the range of those reported in unexposed women. On the contrary, exposure to ESC seems to be significantly associated with some PCs. No adverse effects have been reported in the few studies evaluating its safety during breastfeeding. CONCLUSIONS: The available data seem to support the notion that ESC might be considered safe during pregnancy, in particular as far as MMs is concerned. However, similar to other selective serotonin reuptake inhibitors, it could be associated with an increased risk of PCs. Given the paucity of the studies published so far, no definitive conclusions can be drawn on its safety profile during breastfeeding. Copyright © 2012 John Wiley & Sons, Ltd.
Cesario Bellantuono; Francesca Bozzi; Laura Orsolini; Mario Catena-Dell'osso
Related Documents :
25305765 - Comparison of two guidelines on management of thyroid nodules and thyroid cancer during...
18181085 - Pregnancy complications in women with polycystic ovary syndrome.
15505985 - Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome.
8092965 - Pregnancy outcome data in a united arab emirates population: what can they tell us?
2241485 - Pregnancy diagnosis by milk progesterone on days 18, 22, and 24 postbreeding in dairy c...
14670675 - Successful brainstem cavernous malformation resection after repeated hemorrhages during...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-9
Journal Detail:
Title:  Human psychopharmacology     Volume:  -     ISSN:  1099-1077     ISO Abbreviation:  Hum Psychopharmacol     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8702539     Medline TA:  Hum Psychopharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 John Wiley & Sons, Ltd.
Psychiatric Unit and DEGRA Center, United Hospital of Ancona and Academic Department of Experimental and Clinical Medicine, Polytechnic University of Marche, Ancona, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  RchyOptimyx: cellular hierarchy optimization for flow cytometry.
Next Document:  Time encoded multicolor fluorescence detection in a microfluidic flow cytometer.